The Systolic Blood Pressure Intervention Trial (SPRINT) found evidence of cardiovascular benefit with intensive lowering of systolic blood pressure (goal < 120 mm Hg) compared with the currently recommended goal (< 140 mm Hg) in older patients with cardiovascular risk but without diabetes or stroke. This article reviews the trial design and protocol, summarizes the results, and briefly discusses the implications of these results.
展开▼
机译：收缩压干预试验（SPRINT）发现，有心血管风险但没有糖尿病或高龄的老年患者，与目前推荐的目标值（<140 mm Hg）相比，强烈降低收缩压（目标<120 mm Hg）对心血管有好处。中风。本文回顾了试验设计和方案，总结了结果，并简要讨论了这些结果的含义。
展开▼
